Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Alakasa Industrindo Tbk (ALKA) vs Hetzer Medical Indonesia Tbk. (MEDS) Price & Performance

Alakasa Industrindo Tbk
Hetzer Medical Indonesia Tbk.

Price performance

Price movement over the last 24 hours

Key statistics

Alakasa Industrindo Tbk vs Hetzer Medical Indonesia Tbk. — how do they compare? Alakasa Industrindo Tbk trades at Rp515 (market cap 263.99B, 140.7K 24h volume), while Hetzer Medical Indonesia Tbk. trades at Rp84 (market cap 112.5B, 806.93M 24h volume). The key difference: Alakasa Industrindo Tbk is far larger — about 2.3× Hetzer Medical Indonesia Tbk.'s market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (806.93M versus 140.7K). Which is the better fit depends on your goals.

ALKAMEDS
Market Cap
263.99B112.5B
Volume
140.7K806.93M
Lot
1.41K8.07M
Turnover
73.46M71.46B
Average Price
522.0888.56
Value
73.46M71.46B
Indicative Equilibrium Price
51584
Indicative Equilibrium Volume
15102.91K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ALKA
View details
MEDS
View details

About Alakasa Industrindo Tbk

PT. Alakasa Industrindo Tbk was established on February 21, 1972 within the framework of the foreign capital Investment law N0. 1 1967, under the name of PT Alcan Indonesia, as a join venture enterprise (PMA company) between Alcan Aluminium Holding Ld (Alcan) and the Municipal Government of Jakarta. In August 1988, Alcan sold all of its shares to the Municipal Government of Jakarta (DKI) and the company status was consequently changed to a Domestic Capital Investment Company (PMDN Company). The Company’s name was then changed to PT Alumindo Perkasa.

Read more on ALKA

About Hetzer Medical Indonesia Tbk.

PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.

Read more on MEDS